Home » Topics » BioWorld MedTech

BioWorld MedTech
RSS

CAMBRIDGE BIO ENTERS PRIVATE LABEL PACT

Feb. 25, 1992

TSI SHARES ELIGIBLE FOR CONVERSION

Feb. 25, 1992

RISK POLICY PAVES WAY FOR BIOTECH RULES

Feb. 25, 1992

MGI FILES FOR SALAGEN APPROVAL

Feb. 25, 1992

GRANT FOR DNA IDENTIFICATION SYSTEM

Feb. 25, 1992

ICOS BACK TO THE FUNDING WELL

Feb. 25, 1992

SOMATOGEN BLOOD SUBSTITUTE ENTERS TRIALS

Feb. 25, 1992

POWERFUL NEW IMMUNE BLOCKER

Feb. 24, 1992

DIATECH RAISES FIRST-ROUND FUNDS

Feb. 24, 1992

IMMU FILES FOR CANADIAN APPROVAL

Feb. 24, 1992

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 14, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 14, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
LINC01116 has prognostic value in lung cancer, study shows
BioWorld MedTech
Long noncoding RNAs (lncRNAs) have emerged as potential markers of disease, since they associate with proteins that regulate gene expression, translation or...
SERPINB1 as potential biomarker for spinocerebellar ataxia type 2
BioWorld Science
Researchers from Goethe-Universität and collaborators investigated novel molecular biomarker candidates for spinocerebellar ataxia type 2, a progressive...